SCHEMBL5742922

SCHEMBL5742922

OC(c1ccccc1Cl)c1cccc(Cl)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.50
NFKB1 P19838 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
PNMT P11086 1/20 0.50
LMNA P02545 2/20 0.48
ALDH1A1 P00352 1/20 0.48
GLA P06280 1/20 0.48
IDO1 P14902 1/20 0.44
TDO2 P48775 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TSHR P16473 3/20 0.43
ADRB2 P07550 2/20 0.42
ADRB1 P08588 2/20 0.42
AOC3 Q16853 1/20 0.42
HIF1A Q16665 1/20 0.41
KCNH2 Q12809 1/20 0.41
BLM P54132 1/20 0.40
ACP3 P15309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29976363 0.89 ADRB2 (0.48) CYP2D6NFKB1CYP3A4LMNAALDH1A1
SCHEMBL230382 0.89 ADRB2 (0.48) CYP2D6NFKB1CYP3A4LMNAALDH1A1
SCHEMBL477355 0.83 IDO1 (0.54) CYP2D6NFKB1CYP1A2CYP3A4PNMT
SCHEMBL19856483 0.79 CYP1A2 (0.56) CYP2D6NFKB1CYP1A2CYP3A4PNMT
SCHEMBL4940577 0.77 CYP1A2 (0.54) CYP2D6NFKB1CYP1A2CYP3A4PNMT
SCHEMBL11606505 0.76 TSHR (0.50) CYP2D6NFKB1CYP3A4LMNAALDH1A1
SCHEMBL477580 0.76 ACP3 (0.53) CYP2D6NFKB1CYP3A4LMNAALDH1A1
SCHEMBL29609159 0.76 ACP3 (0.53) CYP2D6NFKB1CYP3A4LMNAALDH1A1
SCHEMBL477602 0.76 ACP3 (0.53) CYP2D6NFKB1CYP3A4LMNAALDH1A1
SCHEMBL7546175 0.76 CYP1A2 (0.63) CYP2D6NFKB1CYP1A2CYP3A4PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620395-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2006-02-01 EP disclosed
EP-1618105-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2006-01-25 EP disclosed
WO-2004096794-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDRS VERNALIS RESEARCH LIMITED (GB) 2004-11-11 WO disclosed
WO-2004096763-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2004-11-11 WO disclosed